LONG COVID SYNDROME
Clinical trials for LONG COVID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LONG COVID SYNDROME trials appear
Sign up with your email to follow new studies for LONG COVID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could blood cleansing beat long COVID fatigue?
Disease control Recruiting nowThis study tests a treatment called immunoadsorption for people with long COVID who have certain antibodies. The treatment filters the blood to remove these antibodies, which may be causing symptoms like extreme fatigue. About 70 participants will receive either the real treatmen…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug aims to ease lingering COVID symptoms
Symptom relief Recruiting nowThis study tests the safety of a drug called NAI (Anktiva) in 40 adults aged 18-70 with long COVID—symptoms that persist after a COVID-19 infection. Researchers will monitor side effects and changes in lab results and vital signs over 30 days after treatment. The goal is to see i…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC
-
Could an old drug beat long COVID? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether the drug plitidepsin can safely improve health in people with Long COVID. About 90 adults with moderate to severe symptoms will receive either the drug or a placebo through IV infusions over 8 weeks. Researchers will measure changes in overall health and …
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Apr 29, 2026 15:04 UTC
-
Heart MRI study aims to spot hidden risks in 6,000 adults
Knowledge-focused Recruiting nowThis study is testing whether a special heart MRI scan can better predict who will develop heart problems, including heart failure or death. Researchers will scan 6,000 adults without known heart disease, including people with Long COVID. The goal is to find early signs of heart …
Matched conditions: LONG COVID SYNDROME
Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:03 UTC